Aarey Drugs & Pharmaceuticals MD, chairman and AGM

Aarey Drugs & Pharmaceuticals board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

ChairpersonMihir R. Ghatalia
Company Secretary and Compliance OfficerKailash Chand Jethlia

6 directors3 independent2 executive1 non-executive

Chetan K MehtaIndependent · joined Jun 2008 · 81 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
Bina GhataliaNon-executive · joined Oct 2023 · 1 listed board · 1 committee seat, 1 as chair
Lalit TulsianiIndependent · joined Jan 2020 · 77 months as independent · 2 listed boards · 2 as independent · 3 committee seats, 2 as chair
Mihir R. Ghatalia · ChairpersonExecutive · joined Aug 2004 · 2 listed boards · 2 committee seats
Nimit R. GhataliaExecutive · joined Jul 2020 · 2 listed boards · 2 committee seats
Anil MandalIndependent · joined Jul 2020 · 72 months as independent · 2 listed boards · 2 as independent · 2 committee seats

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

Board
- 30 Sep 20264 of 6 present3 independent · 24 days in between
- 5 Sep 20266 of 6 present3 independent · 21 days in between
- 14 Aug 20266 of 6 present3 independent · 7 days in between
- 6 Aug 20266 of 6 present3 independent · 67 days in between
1 earlier meeting
- 30 May 20266 of 6 present3 independent
Audit Committee
Chair Chetan K Mehta
Mihir R. Ghatalia, Lalit Tulsiani
- 14 Aug 20263 of 3 present2 independent · 75 days in between
- 30 May 20263 of 3 present2 independent
Nomination and remuneration committee
Chair Lalit Tulsiani
Chetan K Mehta, Bina Ghatalia
- 5 Sep 20263 of 3 present2 independent · 21 days in between
Stakeholders Relationship Committee
Chair Bina Ghatalia
Mihir R. Ghatalia, Chetan K Mehta
No meeting listed in the filing.
Corporate Social Responsibility Committee
Chair Chetan K Mehta
Mihir R. Ghatalia, Lalit Tulsiani
No meeting listed in the filing.

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

Motilal & Associates LLPPeer-review certificate valid to Aug 2026

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Aarey Drugs & Pharmaceuticals AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Aarey Drugs & Pharmaceuticals share news and announcements

Annual general meeting, 30 Sep 2026

13,611 shareholders on the register on 23 Sep 2026; present: 2 promoters and 33 others; votes counted by Virendra G. Bhatt / Virendra G. Bhatt.The company's voting result (opens in a new tab)

TO RECEIVE, CONSIDER AND ADOPT THE AUDITED FINANCIAL STATEMENT OF THE COMPANY FOR THE YEAR ENDED 31ST MARCH, 2026, THE BALANCE SHEET AS ON THAT DATE AND THE REPORTS OF DIRECTORS AND AUDITORS THEREON.
Ordinary
100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 33.88% · promoters 81.20% · institutions 1.26% · other public 5.94%
TO APPOINT A DIRECTOR IN PLACE OF MRS. BINA GHATALIA (DIN:01471745), WHO RETIRES BY ROTATION AND BEING ELIGIBLE, OFFERS HERSELF FOR RE-APPOINTMENT
Ordinary
100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 33.88% · promoters 81.20% · institutions 1.26% · other public 5.94%
APPROVAL OF RELATED PARTY TRANSACTIONS
SpecialPromoters have an interest in it
100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 3.37% · promoters 0.00% · institutions 1.26% · other public 5.94%